A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.
Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
May 10, 23
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
May 10, 23
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending
No related bills have been identified for this legislation.